China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The company is headquartered in Haikou, Hainan and currently employs 224 full-time employees. The company went IPO on 2000-02-15. The firm's products are for human use in connection, and with a variety of high-incidence and high-mortality diseases and medical conditions prevalent. The firm manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. In addition, the Company is also engaged in the production of comprehensive healthcare products and protective products.
CPHI stock price ended at $0.63 on 星期五, after rising 0.00%
On the latest trading day Feb 13, 2026, the stock price of CPHI rose by 0.00%, climbing from $0.63 to $0.63. During the session, the stock saw a volatility of 13.33%, with prices oscillating between a daily low of $0.60 and a high of $0.68. Notably, trading volume dropped by 17.1K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 36.2K shares were traded, equating to a market value of approximately $3.1M.